Search This Blog

Saturday, April 26, 2025

Urogen Updated 18-Month Duration Of Response (Dor) Of 80.6% in Phase 3 Of Ugn-102

 

  • 18-month DOR of 80.6% by Kaplan-Meier estimate was attained in patients who achieved a complete response (CR) at three months (79.6%)

  • Data unveiled during a Podium Presentation at the American Urological Association (AUA) 2025 Annual Meeting in Las Vegas, Nevada

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)